Bio-Techne Corp is a life sciences company that develops, manufactures, and sells reagents, instruments, and services for research, diagnostics, and bioprocessing customers. It operates through two segments: Protein Sciences, which provides antibodies, proteins, immunoassays, and analytical instruments used in life sciences research and drug development, and Diagnostics and Genomics, which offers diagnostic reagents, molecular diagnostics, spatial biology platforms, and related products. Customers include pharmaceutical and biotechnology companies, academic and government research institutions, clinical diagnostic laboratories, and contract research organizations. The company sells primarily through its own direct sales force and distributors, generating revenue from consumable reagent sales, instrument sales, and service contracts. Its largest market is the United States, with additional operations across Europe, the Middle East, Africa, the United Kingdom, Asia-Pacific, and other regions. Bio-Techne is headquartered in Minneapolis, Minnesota.

Piotroski F-Score

Beneish M-Score

PE Ratio

Financial Strength

Altman Z-Score

Operating Margin %

PB Ratio

Revenue per Share

Price

PS Ratio

ROIC vs WACC

Dividend Yield %